MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Biosimilars and Bioanalytical Methods
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

876 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
876 works in the cohort · of 4,299,418page 9 of 18

Labels cover 4 of 876 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 876 of 876 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Biossimilares: Velhas Questões, Novos Desafios
Rita Oliveira, Teresa Aires
2018· article· pt· Gazeta Médica· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+sts+research_integrity+insufficient_payloadconsensus · insufficient_payload
2
citations
aboutno affno abstractunlabeled
Nanomedicine research in Canada
Marianna Földvári
2006· article· en· Nanomedicine Nanotechnology Biology and Medicine· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+stsconsensus · none
2
citations
affunlabeled
Comparison of Pharmacokinetics and Pharmacodynamics of Two Anti-CD20 Monoclonal Antibodies (Candidate Biosimilar DRL-Rituximab and Innovator Reference Product Rituximab (Mabthera®) in a Randomised, Multi-Centre, Double-Blind, Parallel Group Study of CHOP with Rituximab Chemotherapy in Patients with CD20-Positive Diffuse Large B-Cell Lymphoma
Auro Viswabandya, Asis Mukhopadhyay, Sandip Shah, Rajnish Nagarkar, Sonica Sachdeva Batra, Luis López Lázaro +2 more
2016· article· en· Blood· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
2
citations
affno abstractunlabeled
OP0203 Impact of adalimumab serum concentration on efficacy and association between ANTI-DRUG antibodies and serum concentration: 24 week results from a phase III study comparing SB5 (an adalimumab biosimilar) with reference adalimumab in patients with rheumatoid arthritis
Jonathan Kay, M. Weinblatt, Ed Keystone, Mark C. Genovese, Jeehoon Ghil, SY Cheong +1 more
2017· article· en· Annals of the Rheumatic Diseases· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
2
citations
affunlabeled
The Great Debate With IBD Biosimilars
Remo Panaccione
2021· review· en· Crohn s & Colitis 360· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
2
citations
affunlabeled
2025 White Paper on Recent Issues in Bioanalysis: What is the Future of Bioanalytical LIMS? AI/ML Integration in Bioanalysis; Tear Sample Collection; Radiolabeled Mass Balance Studies; Chiral Assays; Bioanalysis of Antibody-Oligonucleotide &amp; Bicycle Drug Conjugates ( <u>PART 1A</u> – Recommendations on Mass Spectrometry Assays, Chromatography, Sample Preparation and Regulated Bioanalysis Sampling, Validating, Analyzing &amp; Reporting <u>PART 1B</u> – Regulatory Agencies’ Input on Regulated Bioanalysis/BMV)
John Wojcik, Mark G. Qian, Anton I. Rosenbaum, Estelle M. Maes, Yongjun Xue, Christopher J. Kochansky +57 more
2025· article· en· Bioanalysis· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+bibliometrics+research_integrity+insufficient_payloadconsensus · metaepi_narrow
2
citations
afffundunlabeled
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS ( <u>PART 3A</u> – Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity &amp; Technologies; Biotherapeutics &amp; Biosimilars Immunogenicity Assessment &amp; Clinical Relevance <u>PART 3B</u> – Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell &amp; Vaccine Therapies)
Omar Tounekti, Sophie Shubow, Sarah Wassmer, Andrea Van Tuyl, Lin Yang, Binsheng Gong +58 more
2025· article· en· Bioanalysis· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+sts+research_integrityconsensus · metaepi_narrow+research_integrity
2
citations
← previousnext →

How this was built: Screen · Findings · About